BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 32164044)

  • 1. Inhibition of Interleukin-6/glycoprotein 130 signalling by Bazedoxifene ameliorates cardiac remodelling in pressure overload mice.
    Shi W; Ma H; Liu T; Yan D; Luo P; Zhai M; Tao J; Huo S; Guo J; Li C; Lin J; Zhang C; Li S; Lv J; Lin L
    J Cell Mol Med; 2020 Apr; 24(8):4748-4761. PubMed ID: 32164044
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alleviation of Inflammation and Oxidative Stress in Pressure Overload-Induced Cardiac Remodeling and Heart Failure via IL-6/STAT3 Inhibition by Raloxifene.
    Huo S; Shi W; Ma H; Yan D; Luo P; Guo J; Li C; Lin J; Zhang C; Li S; Lv J; Lin L
    Oxid Med Cell Longev; 2021; 2021():6699054. PubMed ID: 33824698
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Deletion of Interleukin-6 Attenuates Pressure Overload-Induced Left Ventricular Hypertrophy and Dysfunction.
    Zhao L; Cheng G; Jin R; Afzal MR; Samanta A; Xuan YT; Girgis M; Elias HK; Zhu Y; Davani A; Yang Y; Chen X; Ye S; Wang OL; Chen L; Hauptman J; Vincent RJ; Dawn B
    Circ Res; 2016 Jun; 118(12):1918-1929. PubMed ID: 27126808
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Repositioning Bazedoxifene as a novel IL-6/GP130 signaling antagonist for human rhabdomyosarcoma therapy.
    Xiao H; Bid HK; Chen X; Wu X; Wei J; Bian Y; Zhao C; Li H; Li C; Lin J
    PLoS One; 2017; 12(7):e0180297. PubMed ID: 28672024
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interleukin-10 treatment attenuates pressure overload-induced hypertrophic remodeling and improves heart function via signal transducers and activators of transcription 3-dependent inhibition of nuclear factor-κB.
    Verma SK; Krishnamurthy P; Barefield D; Singh N; Gupta R; Lambers E; Thal M; Mackie A; Hoxha E; Ramirez V; Qin G; Sadayappan S; Ghosh AK; Kishore R
    Circulation; 2012 Jul; 126(4):418-29. PubMed ID: 22705886
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of GP130/STAT3 and EMT by combined bazedoxifene and paclitaxel treatment in ovarian cancer.
    Park SA; Kim LK; Park HM; Kim HJ; Heo TH
    Oncol Rep; 2022 Mar; 47(3):. PubMed ID: 35029286
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Renal denervation attenuates pressure overload-induced cardiac remodelling in rats with biphasic regulation of autophagy.
    Huo JY; Jiang WY; Geng J; Chen C; Zhu L; Chen R; Ge TT; Chang Q; Jiang ZX; Shan QJ
    Acta Physiol (Oxf); 2019 Aug; 226(4):e13272. PubMed ID: 30830723
    [TBL] [Abstract][Full Text] [Related]  

  • 8. C-reactive protein overexpression exacerbates pressure overload-induced cardiac remodeling through enhanced inflammatory response.
    Nagai T; Anzai T; Kaneko H; Mano Y; Anzai A; Maekawa Y; Takahashi T; Meguro T; Yoshikawa T; Fukuda K
    Hypertension; 2011 Feb; 57(2):208-15. PubMed ID: 21220701
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bazedoxifene as a novel GP130 inhibitor for Colon Cancer therapy.
    Wei J; Ma L; Lai YH; Zhang R; Li H; Li C; Lin J
    J Exp Clin Cancer Res; 2019 Feb; 38(1):63. PubMed ID: 30736824
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bazedoxifene exhibits growth suppressive activity by targeting interleukin-6/glycoprotein 130/signal transducer and activator of transcription 3 signaling in hepatocellular carcinoma.
    Ma H; Yan D; Wang Y; Shi W; Liu T; Zhao C; Huo S; Duan J; Tao J; Zhai M; Luo P; Guo J; Tian L; Mageta L; Jou D; Zhang C; Li C; Lin J; Lv J; Li S; Lin L
    Cancer Sci; 2019 Mar; 110(3):950-961. PubMed ID: 30648776
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Repurposing the selective estrogen receptor modulator
    Thilakasiri P; Huynh J; Poh AR; Tan CW; Nero TL; Tran K; Parslow AC; Afshar-Sterle S; Baloyan D; Hannan NJ; Buchert M; Scott AM; Griffin MD; Hollande F; Parker MW; Putoczki TL; Ernst M; Chand AL
    EMBO Mol Med; 2019 Apr; 11(4):. PubMed ID: 30885958
    [TBL] [Abstract][Full Text] [Related]  

  • 12. BMP-7 attenuates left ventricular remodelling under pressure overload and facilitates reverse remodelling and functional recovery.
    Merino D; Villar AV; García R; Tramullas M; Ruiz L; Ribas C; Cabezudo S; Nistal JF; Hurlé MA
    Cardiovasc Res; 2016 Jun; 110(3):331-45. PubMed ID: 27068510
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Continuous glycoprotein-130-mediated signal transducer and activator of transcription-3 activation promotes inflammation, left ventricular rupture, and adverse outcome in subacute myocardial infarction.
    Hilfiker-Kleiner D; Shukla P; Klein G; Schaefer A; Stapel B; Hoch M; Müller W; Scherr M; Theilmeier G; Ernst M; Hilfiker A; Drexler H
    Circulation; 2010 Jul; 122(2):145-55. PubMed ID: 20585009
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IL-6/gp130/STAT3 signaling contributed to the activation of the PERK arm of the unfolded protein response in response to chronic β-adrenergic stimulation.
    Men L; Guo J; Cao Y; Huang B; Wang Q; Huo S; Wang M; Peng D; Peng L; Shi W; Li S; Lin L; Lv J
    Free Radic Biol Med; 2023 Aug; 205():163-174. PubMed ID: 37307935
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bazedoxifene as a Novel GP130 Inhibitor for Pancreatic Cancer Therapy.
    Wu X; Cao Y; Xiao H; Li C; Lin J
    Mol Cancer Ther; 2016 Nov; 15(11):2609-2619. PubMed ID: 27535971
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Eplerenone prevents adverse cardiac remodelling induced by pressure overload in atrial natriuretic peptide-null mice.
    Franco V; Chen YF; Feng JA; Li P; Wang D; Hasan E; Oparil S; Perry GJ
    Clin Exp Pharmacol Physiol; 2006 Sep; 33(9):773-9. PubMed ID: 16922805
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induced NCX1 overexpression attenuates pressure overload-induced pathological cardiac remodelling.
    Ujihara Y; Iwasaki K; Takatsu S; Hashimoto K; Naruse K; Mohri S; Katanosaka Y
    Cardiovasc Res; 2016 Sep; 111(4):348-61. PubMed ID: 27229460
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long Non-Coding RNA Malat-1 Is Dispensable during Pressure Overload-Induced Cardiac Remodeling and Failure in Mice.
    Peters T; Hermans-Beijnsberger S; Beqqali A; Bitsch N; Nakagawa S; Prasanth KV; de Windt LJ; van Oort RJ; Heymans S; Schroen B
    PLoS One; 2016; 11(2):e0150236. PubMed ID: 26919721
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The antioxidant tempol attenuates pressure overload-induced cardiac hypertrophy and contractile dysfunction in mice fed a high-fructose diet.
    Chess DJ; Xu W; Khairallah R; O'Shea KM; Kop WJ; Azimzadeh AM; Stanley WC
    Am J Physiol Heart Circ Physiol; 2008 Dec; 295(6):H2223-30. PubMed ID: 18931030
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adiponectin deficiency exacerbates cardiac dysfunction following pressure overload through disruption of an AMPK-dependent angiogenic response.
    Shimano M; Ouchi N; Shibata R; Ohashi K; Pimentel DR; Murohara T; Walsh K
    J Mol Cell Cardiol; 2010 Aug; 49(2):210-20. PubMed ID: 20206634
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.